Citation

Brugal MT, Barrio G, de la Fuente L, Regidor E, Royuela L, Suelves JM. Addiction 2002; 97(3): 319-327.

Affiliation

Institut Municipal de Salut Pública, Ayuntamiento de Barcelona, Universidad Autónoma de Barcelona, Spain. tbrugal@imsb.bcn.es

Copyright

(Copyright © 2002, John Wiley and Sons)

DOI

unavailable

PMID

11964108

Abstract

AIMS: To examine risk factors associated with non-fatal heroin overdose, particularly frequency and route of heroin administration. DESIGN: Data from cross-sectional surveys were analysed as a case-control and as a case cross-over design. SETTING AND PARTICIPANTS: 2556 subjects treated for heroin dependence in 164 outpatient facilities in Spain. MEASUREMENTS: Prevalence of overdose involving emergency care in the 12 months before treatment admission. CASE CONTROL DESIGN: Odds ratio (OR) adjusted by logistic regression. CASE-CROSSOVER DESIGN: Estimated relative risk (RR) of transient risk of injecting heroin. FINDINGS: The prevalence of overdose was 10%. In the case control analysis the cumulative risk of overdose increased as the frequency of heroin use decreased. However, among daily heroin users this risk increased as the frequency of heroin injection rose, with an OR of 6.0 (95% CI: 3.9-9.6) for daily injectors versus non-injectors. Sniffers had a higher risk than smokers among non-daily users, but not among daily users. Other factors associated with increased risk of overdose were: tranquilizers, alcohol or cocaine use, living in certain regions and being long-term HIV+ 0. In the case-crossover analysis, the RR for injecting heroin versus using other routes immediately before overdose was 15.9 (95% CI: 9.5-26.6), and was much higher for non-daily heroin users than for daily users. CONCLUSIONS: These findings suggest that the rapid entry of a large quantity of heroin into the blood (as occurs when injecting) involves a high risk of overdose, especially when the heroin tolerance level is low (as occurs in sporadic users).

Language: en